What Happened?

The Government of India has imposed an immediate ban on 16 Fixed-Dose Combination (FDC) drugs. The Ministry of Health and Family Welfare issued the orders under Section 26A of the Drugs and Cosmetics Act, effectively halting the manufacture, sale, and distribution of these medicines across India with immediate effect.

The decision came after a thorough scientific review concluded that these specific drug combinations offered no real therapeutic value to patients and could pose risks to public health. The banned formulations span multiple medical categories — from antibiotics and pain relievers to skin care and anti-diabetic drugs.

The expert panel concluded that the continued use of these formulations was not considered beneficial when weighed against the potential risks involved.

Why Were These Drugs Banned?

The ban originates from a Supreme Court-mandated review of the Indian drug market. Following the court’s directive, the Drugs Technical Advisory Board (DTAB) formed a dedicated expert committee to evaluate potentially harmful drug formulations currently available in the market.

After carefully reviewing clinical data for each combination, the expert panel found that these 16 FDC drugs lacked scientific justification for their combined use. Combining multiple active ingredients into one tablet or capsule is only medically valid when the combination provides proven benefits over using each drug separately. In these 16 cases, that evidence was found to be absent.

The Health Ministry emphasized that this decision is part of the government’s broader commitment to promote the rational use of medicines and ensure that only scientifically validated drugs remain available to Indian patients. Similar bans have been carried out in previous years against other irrational drug combinations.

Which Categories Are Affected?

The banned combinations span a wide range of therapeutic categories:

Complete List of 16 Banned FDC Drugs

What Does This Mean for Patients?

If you are currently using any of the above drug combinations, do not panic — but do consult your doctor at the earliest. Your physician can recommend alternative, scientifically approved medications that will safely and effectively address your condition.

Pharmacies and chemists across India are required to immediately stop selling these combinations. Manufacturers must halt production and withdraw existing stock from the market under the legal authority of Section 26A of the Drugs and Cosmetics Act.